Workflow
PetVivo (PETV)
icon
Search documents
PetVivo (PETV) - 2024 Q4 - Annual Report
2024-06-28 20:44
Market Information Dividends From January 2024 to March 2024, the Company issued 324,000 shares of common stock to four consultants for services provided to the Company valued at $333,660. All of these transactions described above were exempt from registration in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended, as a transaction by an issuer not involving a public offering. The purchasers of securities in each of these transactions represented their intention to acquire securities for i ...
PetVivo Reports Reports Fiscal 2024 Results
GlobeNewswire News Room· 2024-06-28 20:41
Fiscal 2024 Financial Highlights Fiscal 2024 Operational Highlights Management Commentary "Also during the year, we developed clinical data on the safety and efficacy of Spryng, increased distribution through the addition of Covetrusm, expanded our efforts with MWI, and increased market awareness of Spryng to veterinarians. "The release of tolerance clinical results involving the injection of Spryng into the joints of canines and felines have confirmed the long-known understanding that Spryng is a safe opti ...
PetVivo Sets Fiscal Fourth Quarter 2024 Conference Call for Friday, June 28 at 5:00 p.m. ET
GlobeNewswire News Room· 2024-06-25 20:15
PetVivo management will host the presentation, followed by a question-and-answer period. If you require any assistance connecting to the call, please contact CMA at 1-949-432-7566. For more information about PetVivo and its revolutionary Spryng with OsteoCushion Technology, email info1@petvivo.com or visit petvivo.com or sprynghealth.com. The foregoing information regarding PetVivo Holdings, Inc. (the "Company") may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act ...
PetVivo Appoints Former NOVUS and Colgate-Palmolive Senior Sales & Marketing Executive, Bryan Monninger, as VP of Sales
GlobeNewswire News Room· 2024-06-06 11:00
MINNEAPOLIS, MN, US, June 06, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, has appointed Bryan Monninger to vice president of sales. In this new position, he will lead the PetVivo's sales and distribution teams, with a focus on expanding the market adoption of the company's innovative animal osteoarthritis medical product, Spryng™ with OsteoCushion™ Technology. Monninger b ...
PetVivo (PETV) - 2024 Q3 - Earnings Call Transcript
2024-02-13 03:04
PetVivo Holdings, Inc. (OTC:PETV) Q3 2024 Earnings Conference Call February 12, 2024 5:00 PM ET Company Participants John Dolan - Chief Business Development Officer & General Counsel John Lai - CEO & President Bob Folkes - CFO Conference Call Participants Operator Hello, and welcome to the PetVivo's Holding 2024 Fiscal Year and Third Quarter 2023 (sic) Earnings Call. Thank you for joining us this afternoon. I'd like to welcome John Dolan, Chief Business Development Officer and General Counsel for PetVivo. J ...
PetVivo (PETV) - 2024 Q3 - Quarterly Report
2024-02-12 21:25
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File No. 001-40715 PetVivo Holdings, Inc. (Name of small business issuer in its charter) (State or other jurisdiction of incorporation or o ...
PetVivo (PETV) - 2024 Q2 - Earnings Call Transcript
2023-11-14 23:46
PetVivo Holdings, Inc. (OTC:PETV) Q2 2024 Earnings Conference Call November 14, 2023 5:00 PM ET Company Participants John Dolan - Chief Business Development Officer & General Counsel John Lai - Chief Executive Officer & President Bob Folkes - Chief Financial Officer Conference Call Participants Operator Welcome, everyone, to the PetVivo Holdings, Inc., 2024 Fiscal Year Second Quarter Earnings Report. This is November 14, 2023, and I will now hand over to Mr. John Dolan to start the call. John Dolan Thank yo ...
PetVivo (PETV) - 2024 Q2 - Quarterly Report
2023-11-14 20:15
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File No. 001-40715 PetVivo Holdings, Inc. (Name of small business issuer in its charter) (State or other jurisdiction of incorporation or ...
PetVivo (PETV) - 2024 Q1 - Earnings Call Transcript
2023-08-11 15:57
PetVivo Holdings, Inc. (OTC:PETV) Q1 2024 Earnings Conference Call August 10, 2023 5:00 PM ET Company Participants John Dolan - Chief Business Development Officer & General Counsel John Lai - CEO, President, & Director Bob Folkes - CFO Conference Call Participants Operator All right. Welcome, everyone, to the PetVivo Holdings, Inc., 2024 Fiscal Year First Quarter Earnings Report. We will now hand over to John Dolan and take it from there. Thank you. John Dolan Thank you, operator. Greetings, and welcome to ...
PetVivo (PETV) - 2024 Q1 - Quarterly Report
2023-08-10 20:20
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File No. 001-40715 PetVivo Holdings, Inc. (Name of small business issuer in its charter) (State or other jurisdiction of incorporation or organ ...